| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |